Search Results - P Curci
- Showing 1 - 11 results of 11
-
1
-
2
-
3
P948: INCIDENCE AND CLINICAL OUTCOME OF SARS-COV-2 INFECTION AFTER VACCINATION IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS) by N. Sgherza, P. Curci, R. Rizzi, D. Roccotelli, M. Croce, M. Avantaggiato, L. Ruga, A. Vitucci, A. Palma, D. Di Gennaro, P. Musto
Published in HemaSphere (2022-06-01)Get full text
Article -
4
P17: DARATUMUMAB (D) PLUS LENALIDOMIDE (R) AND DEXAMETHASONE (D) AS SALVAGE THERAPY FOR PATIENTS WITH REFRACTORY-RELAPSED MULTIPLE MYELOMA (RRMM): INITIAL FOLLOW-UP OF AN ITALIAN M... by G Mele, N Cascavilla, N Di Renzo, A Guarini, P Mazza, L Melillo, V Pavone, G Tarantini, P Curci, AP Falcone, C Germano, A Mele, G Palazzo, G Palumbo, G Reddiconto, B Rossini, G Specchia, P Musto, D Pastore
Published in HemaSphere (2022-04-01)Get full text
Article -
5
P18: DARATUMUMAB (D) PLUS BORTEZOMIB (V) AND DEXAMETHASONE (D) AS SALVAGE THERAPY FOR PATIENTS WITH REFRACTORY/RELAPSED MULTIPLE MYELOMA (RRMM): INITIAL FOLLOW-UP OF AN ITALIAN MUL... by G Mele, N Cascavilla, N Di Renzo, A Guarini, P Mazza, L Melillo, V Pavone, G Tarantini, P Curci, AP Falcone, C Germano, A Mele, G Palazzo, G Palumbo, G Reddiconto, B Rossini, G Specchia, P Musto, D Pastore
Published in HemaSphere (2022-04-01)Get full text
Article -
6
PB2016: COMPARISON BETWEEN DRD VS KRD AS SALVAGE THERAPY FOR MULTIPLE MYELOMA PATIENTS IN FIRST RELAPSE: THE REAL LIFE EXPERIENCE OF RETE EMATOLOGICA PUGLIESE (REP) by A. Mele, E. Prete, S. Citiso, G. Mele, D. Pastore, N. Sgherza, P. Curci, P. Musto, A. P. Falcone, N. Cascavilla, C. Germano, T. Giuseppe, G. Reddiconto, N. Di Renzo, G. Palazzo, P. Mazza, B. Rossini, A. Guarini, G. Palumbo, L. M. A. Melillo, V. Pavone
Published in HemaSphere (2022-06-01)Get full text
Article -
7
P932: ON-DEMAND PLERIXAFOR WITH CYCLOPHOSPHAMIDE AND G-CSF FOR HEMATOPOIETIC STEM-CELL MOBILIZATION IN MULTIPLE MYELOMA PATIENTS: FINAL RESULTS OF THE MOZOBL06877 STUDY by R. Mina, F. Bonello, F. Fazio, R. Saccardi, V. Bongarzoni, F. Marchesi, G. Bertuglia, P. Curci, R. M. Lemoli, S. Ballanti, T. Dentamaro, G. Benevolo, A. Capra, R. Floris, P. Tosi, A. Olivieri, D. Rota-Scalabrini, C. Cangialosi, M. Cavo, P. Corradini, G. Milone, M. Boccadoro, A. Larocca
Published in HemaSphere (2022-06-01)Get full text
Article -
8
P174 | EFFICACY AND SAFETY OF ISATUXIMAB, CARFILZOMIB AND DEXAME-THASONE (ISAKD) IN MULTIPLE MYELOMA PATIENTS AT FIRST RELAPSE AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION AND LENALI... by N. Sgherza, P. Curci, O. Battisti, C. Conticello, S. Palmieri, D. Derudas, C. Germano, E.A. Martino, G. Mele, R. Della Pepa, F. Fazio, A. Mele, B. Rossini, G. Palazzo, D. Roccotelli, S. Rasola, M.T. Petrucci, D. Pastore, G. Tarantini, F. Pane, M. Gentile, F. Di Raimondo, E. Resta, P. Musto
Published in Haematologica (2025-09-01)Get full text
Article -
9
P07 BORTEZOMIB-MELPHALAN-PREDNISONE (VMP) VS. LENALIDOMIDE-DEXAMETHASONE (RD) IN REAL-LIFE MULTIPLE MYELOMA PATIENTS INELIGIBLE FOR TRANSPLANT: UPDATED ANALYSIS OF THE RANDOMIZED P... by A. Larocca, M. D’Agostino, N. Giuliani, E. Antonioli, R. Zambello, S. Ronconi, I. D. Vincelli, F. Ciceri, A. P. Falcone, M. Michieli, F. Cattel, A. Capra, M. Grasso, A. M. Cafro, F. Bonello, R. Floris, M. Offidani, E. Sciorsi, G. Pietrantuono, P. Curci, F. Patriarca, M. Cavo, S. Mangiacavalli, G. Benevolo, A. Evangelista, G. Ciccone, M. Boccadoro, B. Bruno, S. Bringhen
Published in HemaSphere (2023-05-01)Get full text
Article -
10
P169 | REAL-WORLD MINIMAL RESIDUAL DISEASE ANALYSIS IN TRANSPLANT-INELIGIBLE MULTIPLE MYELOMA PATIENTS TREATED WITH DARA-VMP VS. DARA-RD IN THE RANDOMIZED PHASE IV REAL MM TRIAL by L. Cani, M. D’Agostino, R. Ria, S. Mangiacavalli, G. Benevolo, N. Giuliani, R. Zambello, S. Terlizzi, K. Mancuso, A.P. Falcone, I. D. Vincelli, A. Liso, F. Patriarca, A. Casson, S. Bringhen, ; A. Evangelista, E. Sciorsi, P. Curci, F. Vassallo, G. Margiotta-Casaluci, M.T. Petrucci, D. Mannina, P. Bertazzoni, I. Attucci, M. Offidani, F. Cattel, G. Ciccone, B. Bruno, M. Boccadoro, A. Larocca
Published in Haematologica (2025-09-01)Get full text
Article -
11
PB1984: ELOTUZUMAB PLUS LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXTENDED 3-YEAR FOLLOW-UP OF AN ITALIAN, MULTICENTER, EXPERIENCE OUTSIDE OF CONTROLL... by A. Bruzzese, D. Derudas, M. Galli, E. A. Martino, S. Rocco, C. Conticello, C. Califano, N. Giuliani, S. Mangicavalli, G. Farina, A. Lombardo, M. Brunori, E. Rossi, E. Antonioli, R. Ria, R. Zambello, N. Di Renzo, G. Mele, G. Marcacci, G. Pietrantuono, G. Palumbo, N. Cascavilla, C. Cerchione, A. Belotti, C. Criscuolo, G. Uccello, P. Curci, E. Vigna, F. Mendicino, E. Iaccino, S. Mimmi, C. Botta, D. Vincelli, N. Sgherza, A. Bonalumi, L. Cupelli, R. Stocchi, M. Martino, S. Ballanti, D. Gangemi, A. Gagliardi, B. Gamberi, A. Pompa, G. Tripepi, F. Frigeri, U. Consoli, S. Bringhen, E. Zamagni, F. Patriarca, V. De Stefano, F. Di Raimondo, S. Palmieri, M. T. Petrucci, M. Offidani, P. Musto, M. Boccadoro, M. Cavo, A. Neri, F. Morabito, M. Gentile
Published in HemaSphere (2022-06-01)Get full text
Article
